Human anti-idiotypic antibodies can be good immunogens as they target FC receptors on antigen-presenting cells allowing efficient stimulation of both helper and cytotoxic T-cell responses.

作者: Lindy G. Durrant , Tina Parsons , Rob Moss , Ian Spendlove , Graham Carter

DOI: 10.1002/IJC.1194

关键词:

摘要: Anti-idiotypic antibodies that mimic tumour-associated antigens can stimulate anti-tumour T-cell responses. In this article, we have studied the role of Fc in presentation epitopes by 2 anti-idiotypic antibodies, 105AD7 and 708. The human monoclonal antibody 105AD7, which mimics CD55, stimulated strong vitro proliferation, γIFN secretion redirected cytotoxicity unprimed T cells from healthy donors. However, removal region anti-idiotype reduced sensitivity assay 1,000-fold, as did inhibiting uptake an excess IgG. mouse 708, CEA, failed to responses on when a IgG1 replaced its region, induced lymphocytes unimmunised Human anti-idiotypes are therefore good immunogens since they target receptors antigen-presenting cells, allowing efficient stimulation both helper cytotoxic immunogenicity other may be enhanced targeting cells. © 2001 Wiley-Liss, Inc.

参考文章(18)
T F Tedder, P M Guyre, L Shen, K Wardwell, N A Fanger, Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. Journal of Immunology. ,vol. 157, pp. 541- 548 ,(1996)
L G Durrant, J H Scholefield, C A Maxwell-Armstrong, S Amin, R A Robins, Vaccine-induced apoptosis: a novel clinical trial end point? Cancer Research. ,vol. 60, pp. 3132- 3136 ,(2000)
Durrant Lg, Scholefield Jh, Carmichael J, Maxwell-Armstrong C, Amin S, Robins Ra, Buckley D, A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55. Clinical Cancer Research. ,vol. 6, pp. 422- 430 ,(2000)
Ian Spendlove, Lindy G. Durrant, Li Li, James Carmichael, Decay accelerating factor (CD55): a target for cancer vaccines? Cancer Research. ,vol. 59, pp. 2282- 2286 ,(1999)
Pedro J Ruiz, Roland Wolkowicz, Ari Waisman, David L Hirschberg, Pnina Carmi, Netta Erez, Hideki Garren, Johannes Herkel, Marcela Karpuj, Lawrence Steinman, Varda Rotter, Irun R Cohen, None, Idiotypic immunization induces immunity to mutated p53 and tumor rejection. Nature Medicine. ,vol. 4, pp. 710- 712 ,(1998) , 10.1038/NM0698-710
R. Orlandi, D. H. Gussow, P. T. Jones, G. Winter, Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 3833- 3837 ,(1989) , 10.1073/PNAS.86.10.3833
R M Chicz, R G Urban, J C Gorga, D A Vignali, W S Lane, J L Strominger, Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. Journal of Experimental Medicine. ,vol. 178, pp. 27- 47 ,(1993) , 10.1084/JEM.178.1.27
Jerry H. Brown, Theodore S. Jardetzky, Joan C. Gorga, Lawrence J. Stern, Robert G. Urban, Jack L. Strominger, Don C. Wiley, Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 Nature. ,vol. 364, pp. 33- 39 ,(1993) , 10.1038/364033A0
C A Maxwell-Armstrong, L G Durrant, R A Robins, A M Galvin, J H Scholefield, J D Hardcastle, Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7 Gut. ,vol. 45, pp. 593- 598 ,(1999) , 10.1136/GUT.45.4.593